Skip to content
2000
image of The Role of Pharmacists in Addressing Non-Adherence among Asthmatic Patients: A Comprehensive Review

Abstract

Introduction

Asthma is a common chronic respiratory condition characterized by inflammation and influenced by genetic and environmental factors. Medication non-adherence is a significant issue that negatively impacts health outcomes and increases healthcare costs globally. This review examines the factors contributing to non-adherence among patients with asthma, its effects on asthma control, and the role of pharmacists in enhancing adherence.

Methods

A comprehensive literature review was conducted to explore the issue of medication non-adherence in asthma management and to examine the important role of pharmacists in this context. Utilizing prominent scientific databases, the review presents evidence-based results.

Results

Various factors contribute to non-adherence, including the chronic nature of asthma, complex treatment regimens, economic status, cognitive abilities, and fear of side effects. These factors lead to poor asthma control and increased healthcare costs. Pharmacists can improve asthma management through education, proper inhaler techniques, and personalized care plans. Interventions, including tailored regimens and technology, show promise for improving adherence.

Discussion

Pharmacists significantly improve asthma management through patient education, ensuring correct inhaler use, and developing personalized care plans. Their involvement is linked to better medication adherence and asthma control, especially when using tailored regimens and digital tools.

Conclusion

Despite challenges in compliance and variability in adherence, evidence supports pharmacist-led interventions as effective for enhancing patient outcomes and quality of life, highlighting the importance of integrating pharmacists into healthcare teams.

Loading

Article metrics loading...

/content/journals/crmr/10.2174/011573398X383444250712214928
2025-07-17
2025-09-17
Loading full text...

Full text loading...

References

  1. Mims J.W. Asthma: Definitions and pathophysiology. Int. Forum Allergy Rhinol. 2015 5 S1 S2 S6 10.1002/alr.21609 26335832
    [Google Scholar]
  2. World Health Organization Asthma. 2024 Available from: https://www.who.int/news-room/fact-sheets/detail/asthma
  3. Kwah J.H. Peters A.T. Asthma in adults: Principles of treatment. Allergy Asthma Proc. 2019 40 6 396 402 10.2500/aap.2019.40.4256 31690379
    [Google Scholar]
  4. Poddighe D. Brambilla I. Licari A. Marseglia G.L. Omalizumab in the therapy of pediatric asthma. Recent Pat. Inflamm. Allergy Drug Discov. 2018 12 2 103 109 10.2174/1872213X12666180430161351 29714140
    [Google Scholar]
  5. Jansen E.M. van de Hei S.J. Dierick B.J.H. Kerstjens H.A.M. Kocks J.W.H. van Boven J.F.M. Global burden of medication non-adherence in chronic obstructive pulmonary disease (COPD) and asthma: A narrative review of the clinical and economic case for smart inhalers. J. Thorac. Dis. 2021 13 6 3846 3864 10.21037/jtd‑20‑2360 34277075
    [Google Scholar]
  6. Gast A. Mathes T. Medication adherence influencing factors—an (updated) overview of systematic reviews. Syst. Rev. 2019 8 1 112 10.1186/s13643‑019‑1014‑8 31077247
    [Google Scholar]
  7. Chatkin J.M. Blanco D.C. Scaglia N. Wagner M.B. Fritscher C.C. Impact of a low-cost and simple intervention in enhancing treatment adherence in a Brazilian asthma sample. J. Asthma 2006 43 4 263 266 10.1080/02770900600620459 16809238
    [Google Scholar]
  8. Abegaz T.M. Shegena E.A. Gessie N.F. Gebreyohanns E.A. Seid M.A. Correction to: Barriers to and competency with the use of metered dose inhaler and its impact on disease control among adult asthmatic patients in Ethiopia. BMC Pulm. Med. 2020 20 1 95 10.1186/s12890‑020‑1122‑1
    [Google Scholar]
  9. Chan A.H.Y. Stewart A.W. Harrison J. Camargo C.A. Jr Black P.N. Mitchell E.A. The effect of an electronic monitoring device with audiovisual reminder function on adherence to inhaled corticosteroids and school attendance in children with asthma: A randomised controlled trial. Lancet Respir. Med. 2015 3 3 210 219 10.1016/S2213‑2600(15)00008‑9 25617215
    [Google Scholar]
  10. Ding B. Small M. Disease burden of mild asthma in China. Respirology 2018 23 4 369 377 10.1111/resp.13189 29052915
    [Google Scholar]
  11. Bereznicki B.J. Chapman M.P. Bereznicki L.R.E. Factors associated with overestimation of asthma control: A cross-sectional study in Australia. J. Asthma 2017 54 4 439 446 10.1080/02770903.2016.1226899 27603169
    [Google Scholar]
  12. AL-Jahdali H. Wali S. Salem G. Al-Hameed F. Almotair A. Zeitouni M. Aref H. Nadama R. Algethami M. Al Ghamdy A. Dihan T. Asthma control and predictive factors among adults in Saudi Arabia: Results from the Epidemiological Study on the Management of Asthma in Asthmatic Middle East Adult Population study. Ann. Thorac. Med. 2019 14 2 148 154 10.4103/atm.ATM_348_18 31007767
    [Google Scholar]
  13. Latry P. Pinet M. Labat A. Magand J. Peter C. Robinson P. Martinlatry K. Molimard M. Adherence to anti-inflammatory treatment for asthma in clinical practice in France. Clin. Ther. 2008 30 Spec No 1058 1068 10.1016/j.clinthera.2008.06.011 18640480
    [Google Scholar]
  14. Manfrin A. Tinelli M. Thomas T. Krska J. A cluster randomised control trial to evaluate the effectiveness and cost-effectiveness of the Italian medicines use review (I-MUR) for asthma patients. BMC Health Serv. Res. 2017 17 1 300 10.1186/s12913‑017‑2245‑9 28438152
    [Google Scholar]
  15. Brown M.T. Bussell J. Dutta S. Davis K. Strong S. Mathew S. Medication adherence: Truth and consequences. Am. J. Med. Sci. 2016 351 4 387 399 10.1016/j.amjms.2016.01.010 27079345
    [Google Scholar]
  16. Klein D. Medication non-adherence: A common and costly problem. 2020 Available from: https://www.panfoundation.org/medication-non-adherence/
  17. Baryakova T.H. Pogostin B.H. Langer R. McHugh K.J. Overcoming barriers to patient adherence: The case for developing innovative drug delivery systems. Nat. Rev. Drug Discov. 2023 22 5 387 409 10.1038/s41573‑023‑00670‑0 36973491
    [Google Scholar]
  18. Fahrni M.L. Saman K.M. Alkhoshaiban A.S. Naimat F. Ramzan F. Isa K.A.M. Patient-reported outcome measures to detect intentional, mixed, or unintentional non-adherence to medication: A systematic review. BMJ Open 2022 12 9 057868 10.1136/bmjopen‑2021‑057868 36123061
    [Google Scholar]
  19. Taqi A. Rowlands G. Rathbone A.P. A systematic review and thematic synthesis to identify factors that influence pharmacists’ involvement in asthma care services: An identity crisis. Explor. Res. Clin. Soc. Pharm. 2021 3 100051 10.1016/j.rcsop.2021.100051 35480619
    [Google Scholar]
  20. Thengilsdóttir G. Pottegård A. Linnet K. Halldórsson M. Almarsdóttir A.B. Gardarsdóttir H. Do patients initiate therapy? Primary non-adherence to statins and antidepressants in Iceland. Int. J. Clin. Pract. 2015 69 5 597 603 10.1111/ijcp.12558 25648769
    [Google Scholar]
  21. Piña I.L. Di Palo K.E. Brown M.T. Choudhry N.K. Cvengros J. Whalen D. Whitsel L.P. Johnson J. Medication adherence: Importance, issues and policy: A policy statement from the American Heart Association. Prog. Cardiovasc. Dis. 2021 64 64 111 120 10.1016/j.pcad.2020.08.003 32800791
    [Google Scholar]
  22. Cea-Calvo L. Marín-Jiménez I. de Toro J. Fuster-RuizdeApodaca M.J. Fernández G. Sánchez-Vega N. Orozco-Beltrán D. Different associations of intentional and non-intentional non-adherence behaviors with patient experience with healthcare and patient beliefs in medications: A survey of patients with chronic conditions. Patient Prefer. Adherence 2020 14 2439 2450 10.2147/PPA.S281985 33363360
    [Google Scholar]
  23. Alosaimi K. Alwafi H. Alhindi Y. Falemban A. Alshanberi A. Ayoub N. Alsanosi S. Medication adherence among patients with chronic diseases in Saudi Arabia. Int. J. Environ. Res. Public Health 2022 19 16 10053 10.3390/ijerph191610053 36011690
    [Google Scholar]
  24. Vrijens B. Dima A.L. Van Ganse E. van Boven J.F.M. Eakin M.N. Foster J.M. de Bruin M. Chisholm A. Price D. What we mean when we talk about adherence in respiratory medicine. J. Allergy Clin. Immunol. Pract. 2016 4 5 802 812 10.1016/j.jaip.2016.05.019 27587314
    [Google Scholar]
  25. Mammen J.R. Turgeon K. Philibert A. Schoonmaker J.D. Java J. Halterman J. Berliant M.N. Crowley A. Reznik M. Feldman J.M. Fortuna R.J. Arcoleo K. A mixed-methods analysis of younger adults’ perceptions of asthma, self-management, and preventive care: “This isn’t helping me none”. Clin. Exp. Allergy 2021 51 1 63 77 10.1111/cea.13751 33007115
    [Google Scholar]
  26. Kebede B. Mamo G. Determinants of non-adherence to inhaled steroids in adult asthmatic patients on follow up in referral hospital, Ethiopia: Cross-sectional study. Asthma Res. Pract. 2019 5 1 5 10.1186/s40733‑019‑0053‑1 31893127
    [Google Scholar]
  27. Agbabiaka T.B. Concurrent use of prescription drugs and herbal medicinal products among older adults. 2020 Available from: https://uhra.herts.ac.uk/handle/2299/22120
  28. Fenta E. Ayal B. Kidie A. Anagaw T. Mekonnen T. Ketema Bogale E. Berihun S. Tsega T.D. Mengistie Munie C. Talie Fenta T. Kassie Worku N. Shiferaw Gelaw S. Tiruneh M.G. Barriers to medication adherence among patients with non-communicable disease in north wollo zone public hospitals: Socio-ecologic perspective, 2023. Patient Prefer. Adherence 2024 18 733 744 10.2147/PPA.S452196 38533490
    [Google Scholar]
  29. Shah T.I. Milosavljevic S. Bath B. Measuring geographical accessibility to rural and remote health care services: Challenges and considerations. Spat. Spatio-Temporal Epidemiol. 2017 21 87 96 10.1016/j.sste.2017.04.002 28552191
    [Google Scholar]
  30. Daniel R.A. Aggarwal P. Kalaivani M. Gupta S.K. Prevalence of asthma among children in India. Lung India 2022 39 4 357 367 10.4103/lungindia.lungindia_706_21 35848669
    [Google Scholar]
  31. Standard treatment workflows of India. 2019 Available from: https://www.icmr.gov.in/downloadable-books
  32. Bridgeman M.B. Wilken L.A. Essential role of pharmacists in asthma care and management. J. Pharm. Pract. 2021 34 1 149 162 10.1177/0897190020927274 32495701
    [Google Scholar]
  33. Deka H. Mahanta P. Ahmed S.J. Rajbangshi M.C. Konwar R. Basumatari B. Risk factors of childhood asthma among patients attending a tertiary care centre in north-east India. J. Asthma Allergy 2022 15 1293 1303 10.2147/JAA.S374007 36132976
    [Google Scholar]
  34. Jat K.R. Kabra S.K. Awareness about childhood asthma. Indian J. Med. Res. 2017 145 5 581 583 10.4103/ijmr.IJMR_420_17 28948946
    [Google Scholar]
  35. Al Mazrouei K. Almannaei A.I. Nur F.M. Bachnak N. Alzaabi A. Direct and indirect costs of asthma burden in abu dhabi: A retrospective analysis of insurance claims data from 2015 to 2018. Clinicoecon. Outcomes Res. 2021 13 969 980 10.2147/CEOR.S331499 35002264
    [Google Scholar]
  36. Mubarak N. Hatah E.M. Khan T.M. Zin C.S. A systematic review and meta-analysis of the impact of collaborative practice between community pharmacist and general practitioner on asthma management. J. Asthma Allergy 2019 12 109 153 10.2147/JAA.S202183 31213852
    [Google Scholar]
  37. Zhang X. Ding R. Zhang Z. Chen M. Yin Y. Quint J.K. Medication adherence in people with asthma: A qualitative systematic review of patient and health professional perspectives. J Asthma Allergy 2023 16 515 527 10.2147/JAA.S407552
    [Google Scholar]
  38. Augustine J.M. Taylor A.M. Pelger M. Schiefer D. Warholak T.L. Smoking quit rates among patients receiving pharmacist-provided pharmacotherapy and telephonic smoking cessation counseling. J. Am. Pharm. Assoc. 2016 56 2 129 136 10.1016/j.japh.2016.02.001 27000162
    [Google Scholar]
  39. Paoletti G. Keber E. Heffler E. Malipiero G. Baiardini I. Canonica G.W. Giua C. Comar C. Vaiarelli K. Gioiella G. Aprile C. Basile A. Battisti A. Cavalli C. Cirino M. Bella M.D. Demontis R. Di Donato G. Di Gangi R. Esposito A. Falanga G. Ghetti P. Fimiani G. Florio A. Floris E. Fontanesi A. Giuffrida A. Guccione C. Lancia L. Lanzoni A.M. Leo A. Leone C. Levantino P. Marchionni M. Miccichè M. Moneghini F. Policicchio P. Rauseo A. Romano F. Sequenza M.J. Stabile S. Zacchia M. Zanetti S.I. Effect of an educational intervention delivered by pharmacists on adherence to treatment, disease control and lung function in patients with asthma. Respir. Med. 2020 174 106199 106199 10.1016/j.rmed.2020.106199 33120195
    [Google Scholar]
  40. Ghimire A. Allison R. Lichtemberg Y. Vempilly J.J. Jain V.V. A single home visit improves adherence and reduces healthcare utilization in patients with frequent exacerbations of Severe Asthma and COPD. Respir. Med. X 2021 3 100026 10.1016/j.yrmex.2021.100026
    [Google Scholar]
  41. Valentino A.S. Eddy E. Woods Z. Wilken L. Pharmacist provided spirometry services: A scoping review. Integr. Pharm. Res. Pract. 2021 10 93 111 10.2147/IPRP.S248705 34485107
    [Google Scholar]
  42. Kumar A.H. Kuruvilla J. Thomas V. Maximising patient care: The crucial role of clinical pharmacists in virtual hospital and telehealth settings: A review. Indian J. Pharma. Pract. 2025 18 3 262 265 10.5530/ijopp.20250228
    [Google Scholar]
  43. Role of clinical pharmacist in telemedicine and its status in India. 2023 Available from: https://timesofindia.indiatimes.com/readersblog/drhemantbareth/role-of-clinical-pharmacist-in-telemedicine-and-its-status-in-india-50490/
  44. Kini V. Ho P.M. Interventions to improve medication adherence. JAMA 2018 320 23 2461 2473 10.1001/jama.2018.19271 30561486
    [Google Scholar]
  45. Costa E. Pecorelli S. Giardini A. Savin M. Menditto E. Lehane E. Laosa O. Monaco A. Marengoni A. Interventional tools to improve medication adherence: Review of literature. Patient Prefer. Adherence 2015 9 1303 1314 10.2147/PPA.S87551 26396502
    [Google Scholar]
  46. Cross A.J. Elliott R.A. Petrie K. Kuruvilla L. George J. Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications. Cochrane Database Syst. Rev. 2020 5 5 CD012419 32383493
    [Google Scholar]
  47. Bayatra A. Nasserat R. Ilan Y. Overcoming low adherence to chronic medications by improving their effectiveness using a personalized second-generation digital system. Curr. Pharm. Biotechnol. 2024 25 16 2078 2088 10.2174/0113892010269461240110060035 38288794
    [Google Scholar]
  48. Xu H.Y. Yu Y.J. Zhang Q.H. Hu H.Y. Li M. Tailored interventions to improve medication adherence for cardiovascular diseases. Front. Pharmacol. 2020 11 510339 10.3389/fphar.2020.510339 33364935
    [Google Scholar]
  49. Seetharama S.D. Shriya A.S.K. Pawar V.B. Gupta B.S. Palaksha S. Assessment of medication adherence and common non-adherence: A routinely overlooked hurdle. Int. J. Pharm. Investig. 2024 14 4 1079 1084 10.5530/ijpi.14.4.118
    [Google Scholar]
  50. Elnaem M.H. Irwan N.A. Abubakar U. Sulaiman S.S.A. Elrggal M.E. Cheema E. Impact of medication regimen simplification on medication adherence and clinical outcomes in patients with long-term medical conditions. Patient Prefer. Adherence 2020 14 2135 2145 10.2147/PPA.S268499 33173282
    [Google Scholar]
  51. Global institute for asthma. 2016 Available from: http://www.ginasthma.org
  52. Mclean W. Gillis J. Waller R. The BC community pharmacy asthma study: A study of clinical, economic and holistic outcomes influenced by an asthma care protocol provided by specially trained community pharmacists in british columbia. Can. Respir. J. 2003 10 4 195 202 10.1155/2003/736042 12851665
    [Google Scholar]
  53. Mehuys E. Van Bortel L. De Bolle L. Van Tongelen I. Annemans L. Remon J.P. Brusselle G. Effectiveness of pharmacist intervention for asthma control improvement. Eur. Respir. J. 2008 31 4 790 799 10.1183/09031936.00112007 18094011
    [Google Scholar]
  54. Ottenbros S. Teichert M. de Groot R. Griens F. Sodihardjo F. Wensing M. de Gier J.J. Pharmacist-led intervention study to improve drug therapy in asthma and COPD patients. Int. J. Clin. Pharm. 2014 36 2 336 344 10.1007/s11096‑013‑9887‑4 24293335
    [Google Scholar]
  55. Grover C, Medication education program for indian children with asthma: A feasibility study. Nigerian J Clin Practice 2016 19 1 76 10.4103/1119‑3077.173716
    [Google Scholar]
  56. Barbanel D. Eldridge S. Griffiths C. Can a self-management programme delivered by a community pharmacist improve asthma control? A randomised trial. Thorax 2003 58 10 851 854 10.1136/thorax.58.10.851 14514935
    [Google Scholar]
  57. Basheti I. Mahboub B. Salameh L. Al-Ani M. Jairoun A.A. Saddik B. Abu-Gharbieh E. Assessment of novel inhaler technique reminder labels in image format on the correct demonstration of inhaler technique skills in asthma: A single-blinded randomized controlled trial. Pharmaceuticals 2021 14 2 150 10.3390/ph14020150 33673280
    [Google Scholar]
  58. De Simoni A. Fleming L. Holliday L. Horne R. Priebe S. Bush A. Sheikh A. Griffiths C. Electronic reminders and rewards to improve adherence to inhaled asthma treatment in adolescents: A non-randomised feasibility study in tertiary care. BMJ Open 2021 11 10 053268 10.1136/bmjopen‑2021‑053268 34716166
    [Google Scholar]
  59. Nguyen T.T. Truong M.T.Xuan Dung L.N. Le T.T.T. Effect of pharmacist-led interventions on medication adherence among vietnamese patients with asthma: A randomized controlled trial. Adv. Respir. Med. 2023 2023 91 254 267 10.3390/arm91030020
    [Google Scholar]
  60. Bhattarai A. Shakya R. Bista D. Impact of pharmacist-led intervention on adherence to inhalers, inhalation technique, and disease control among asthma/copd patients in a resource limited center: An interventional study. Patient Prefer. Adherence 2024 18 1395 1408 10.2147/PPA.S460810 38974680
    [Google Scholar]
  61. Dang A. Kim T. Effect of pharmacist-led training on adherence and practice of inhaler use: A pre-post interventional study in outpatients with asthma at hue university hospital. Senior Care Pharmacist. 2024 39 2 78 86 10.4140/TCP.n.2024.78
    [Google Scholar]
  62. Alvarez-Perea A. Dimov V. Popescu F.D. Zubeldia J.M. The applications of eHealth technologies in the management of asthma and allergic diseases. Clin. Transl. Allergy 2021 11 7 12061 10.1002/clt2.12061 34504682
    [Google Scholar]
  63. Mosnaim G. Safioti G. Brown R. DePietro M. Szefler S.J. Lang D.M. Portnoy J.M. Bukstein D.A. Bacharier L.B. Merchant R.K. Digital health technology in asthma: A comprehensive scoping review. J. Allergy Clin. Immunol. Pract. 2021 9 6 2377 2398 10.1016/j.jaip.2021.02.028 33652136
    [Google Scholar]
  64. Pleasants R.A. Chan A.H.Y. Mosnaim G. Costello R.W. Dhand R. Schworer S.A. Merchant R. Tilley S.L. Integrating digital inhalers into clinical care of patients with asthma and chronic obstructive pulmonary disease. Respir. Med. 2022 205 107038 10.1016/j.rmed.2022.107038 36446239
    [Google Scholar]
  65. Chan A.H.Y. Pleasants R.A. Dhand R. Tilley S.L. Schworer S.A. Costello R.W. Merchant R. Digital inhalers for asthma or chronic obstructive pulmonary disease: A scientific perspective. Pulm. Ther. 2021 7 2 345 376 10.1007/s41030‑021‑00167‑4 34379316
    [Google Scholar]
  66. van Boven J.F.M. Kocks J.W.H. Dierick B.J.H. Digital inhaler implementation in daily asthma management: Who, when, and how? J. Allergy Clin. Immunol. Pract. 2024 12 2 396 398 10.1016/j.jaip.2023.12.038 38336396
    [Google Scholar]
/content/journals/crmr/10.2174/011573398X383444250712214928
Loading
/content/journals/crmr/10.2174/011573398X383444250712214928
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test